BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
9 results:

  • 1. lrp1b-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
    Kolb S; Hoffmann I; Monjé N; Dragomir MP; Jank P; Bischoff P; Keunecke C; Pohl J; Kunze CA; Marchenko S; Schmitt WD; Kulbe H; Sers C; Sehouli J; Braicu EI; Denkert C; Darb-Esfahani S; Horst D; Sinn BV; Taube ET
    Hum Pathol; 2023 Nov; 141():158-168. PubMed ID: 37742945
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3.
    Li J; Chen Z; Xiao W; Liang H; Liu Y; Hao W; Zhang Y; Wei F
    J Cell Mol Med; 2023 Nov; 27(21):3259-3270. PubMed ID: 37525498
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
    Gan M; Tai Z; Yu Y; Zhang C; Xu J
    PeerJ; 2023; 11():e14653. PubMed ID: 36721777
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. lrp1b Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in ovarian cancer.
    Dionísio de Sousa IJ; Cunha AI; Saraiva IA; Portugal RV; Gimba ERP; Guimarães M; Prazeres H; Lopes JM; Soares P; Lima RT
    Pathobiology; 2021; 88(6):400-411. PubMed ID: 34689147
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced ovarian
    Shen W; Shan B; Liang S; Zhang J; Yu Y; Zhang Y; Wang G; Bai Y; Qian B; Lu J; Jiang Z
    Pathol Oncol Res; 2021; 27():581534. PubMed ID: 34257528
    [No Abstract]    [Full Text] [Related]  

  • 6. A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
    Zhang Y; Shi X; Zhang J; Chen X; Zhang P; Liu A; Zhu T
    Sci Rep; 2021 Jan; 11(1):387. PubMed ID: 33432021
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
    Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
    Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. lrp1b deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.
    Cowin PA; George J; Fereday S; Loehrer E; Van Loo P; Cullinane C; Etemadmoghadam D; Ftouni S; Galletta L; Anglesio MS; Hendley J; Bowes L; Sheppard KE; Christie EL; Pearson RB; Harnett PR; Heinzelmann-Schwarz V; Friedlander M; McNally O; Quinn M; Campbell P; deFazio A; Bowtell DD;
    Cancer Res; 2012 Aug; 72(16):4060-73. PubMed ID: 22896685
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.